Unresectable Breast Cancer
Drug | Drug Name | Drug Description |
---|---|---|
DB14962 | Trastuzumab deruxtecan | An antibody used to treat certain types of unresectable or metastatic HER2 positive breast cancer. |
DB11652 | Tucatinib | A kinase inhibitor used to treat certain types of unresectable/metastatic HER-2 positive breast cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB12483 | Copanlisib | 1 | Terminated | 1 |
DB01006 | Letrozole | 1 | Withdrawn | 1 |
DB12637 | Onapristone | 1 | Withdrawn | 1 |
DB09073 | Palbociclib | 1 | Withdrawn | 1 |
DB05773 | Trastuzumab emtansine | 1 | Terminated | 1 |
DB14962 | Trastuzumab deruxtecan | Not Available | Recruiting | 1 |